首页> 外国专利> Chalcone derivatives optical isomer thereof or pharmaceutically acceptable salts thereof and a pharmaceutical composition for preventing or treating mitochondrial disease induced by decrease of oxygen consumption rate comprising the same as an active ingredient

Chalcone derivatives optical isomer thereof or pharmaceutically acceptable salts thereof and a pharmaceutical composition for preventing or treating mitochondrial disease induced by decrease of oxygen consumption rate comprising the same as an active ingredient

机译:查尔酮衍生物的光学异构体或其药学上可接受的盐以及用于预防或治疗因耗氧率降低而引起的线粒体疾病的药物组合物,其包含活性成分

摘要

The present invention relates to a chalcone derivative compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the chalcone derivative compound as an active ingredient, a neurodegenerative disease, attention deficit hyperactivity disorder, The present invention relates to a pharmaceutical composition for preventing or treating a disease caused by a decrease in oxygen consumption rate of mitochondria selected from liver diseases. When the chalcone derivative is treated, the activity to increase the oxygen consumption rate in mitochondria is excellent, Or a pharmaceutically acceptable salt thereof.;
机译:查尔酮衍生物化合物,其旋光异构体或其药学上可接受的盐以及药物组合物技术领域本发明涉及查尔酮衍生物化合物,其光学异构体或其药学上可接受的盐以及包含该查尔酮衍生物化合物作为有效成分,神经退行性疾病,注意力缺陷多动障碍的药物组合物。用于预防或治疗由选自肝病的线粒体的耗氧率降低引起的疾病的药物组合物。当处理查耳酮衍生物时,提高线粒体中的耗氧率的活性或其药学上可接受的盐。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号